Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

F. Feu, J. C. García-Pagán, J. Bosch, A. Luca, A. Escorsell, J. Rodés, J. Terés

Research output: Contribution to journalArticlepeer-review

Abstract

Summary. In patients with variceal bleeding as a complication of hepatic cirrhosis, propranolol therapy reduces the risk of recurrent variceal haemorrhage. However, the relation between portal pressure response to pharmacological treatment and clinical events has not been well defined. This relation was prospectively investigated in 69 cirrhotic patients receiving continued propranolol therapy after an episode of variceal bleeding. Hepatic venous pressure gradient (HVPG) was measured before and at 3 months of continued drug therapy. At 3 months HVPG had fallen by 20% or more in 25 patients. During follow-up of 28 (SD 17) months rebleeding occurred in 2 of these 25 patients compared with 23 of 44 who had lesser reductions in HVPG. Cumulative probability of rebleeding at 1, 2, and 3 years was 4%, 9%, and 9% in patients with a decrease in HVPG {succeeds or equal to}20%, and 28%, 39%, and 66% in patients with a decrease in HVPG

Original languageEnglish
Pages (from-to)1056-1059
Number of pages4
JournalLancet
Volume346
Issue number8982
DOIs
Publication statusPublished - Oct 21 1995

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis'. Together they form a unique fingerprint.

Cite this